EGM
NTLA icon

Engineers Gate Manager’s Intellia Therapeutics NTLA Stock Holding History

Engineers Gate Manager’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
84,728
-35,628
-30% -$499K 0.02% 878
2026
Q1 		$1.54M Buy
120,356
+37,305
+45% +$475K 0.02% 840
2025
Q4 		$747K Sell
83,051
-15,238
-16% -$210K 0.01% 1179
2025
Q3 		$1.7M Sell
98,289
-34,725
-26% -$428K 0.02% 850
2025
Q2 		$1.25M Buy
133,014
+8,450
+7% +$69.4K 0.02% 998
2025
Q1 		$886K Sell
124,564
-23,603
-16% -$238K 0.01% 1132
2024
Q4 		$1.73M Buy
148,167
+96,410
+186% +$1.5M 0.03% 693
2024
Q3 		$1.06M Sell
51,757
-9,771
-16% -$225K 0.02% 952
2024
Q2 		$1.38M Buy
+61,528
New +$1.46M 0.03% 737
2023
Q4 		– Sell
-23,349
Closed -$738K – 2155
2023
Q3 		$738K Buy
23,349
+16,143
+224% +$626K 0.03% 882
2023
Q2 		$294K Sell
7,206
-37,881
-84% -$1.54M 0.01% 1312
2023
Q1 		$1.68M Buy
45,087
+6,520
+17% +$256K 0.07% 371
2022
Q4 		$1.35M Buy
38,567
+10,109
+36% +$481K 0.08% 329
2022
Q3 		$1.59M Buy
+28,458
New +$1.77M 0.1% 252
2021
Q1 		– Sell
-15,150
Closed -$824K – 2033
2020
Q4 		$824K Sell
15,150
-30,288
-67% -$1.1M 0.04% 683
2020
Q3 		$903K Buy
+45,438
New +$947K 0.04% 671
2020
Q2 		– Sell
-24,539
Closed -$300K – 1896
2020
Q1 		$300K Buy
+24,539
New +$331K 0.02% 1040

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Engineers Gate Manager's NTLA Position: Q2 2026 in Review

Engineers Gate Manager reduced its Intellia Therapeutics (NTLA) stake by 30% in Q2 2026, selling an estimated $499K and leaving 84,728 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #878.

Engineers Gate Manager first reported a position in NTLA in Q1 2020 and has held it in 17 quarters since. The position peaked at $1.73M in Q4 2024. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Engineers Gate Manager held 84,728 shares of Intellia Therapeutics worth $1.43M as of Q2 2026.
  • Engineers Gate Manager sold 35,628 Intellia Therapeutics shares in Q2 2026, an estimated $499K.
  • Intellia Therapeutics made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #878 holding.
  • Engineers Gate Manager first reported a position in Intellia Therapeutics in Q1 2020 and has held it in 17 quarters since.
  • Engineers Gate Manager's Intellia Therapeutics position peaked at $1.73M in Q4 2024.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.